Technology | Left Atrial Appendage (LAA) Occluders | February 22, 2018

AtriCure Launches AtriClip FLEX•V Device in the United States

New device offers increased flexibility, easier navigation and placement in left atrial appendage management

AtriCure Launches AtriClip FLEX•V Device in the United States

February 22, 2018 — AtriCure Inc. announced that it has launched the AtriClip FLEX•V Left Atrial Appendage (LAA) Exclusion System in the United States. The new system is the first device of the AtriClip family to offer a clip deployment trigger release. The device also offers an open-ended AtriClip design combined with a tip-first closure mechanism to enable easier navigation and placement in cardiac surgeries. This “V” clip technology builds off the AtriClip PRO•V, which was launched in September of 2017 for minimally-invasive surgery (MIS) applications.

The AtriClip FLEX•V received U.S. Food and Drug Administration (FDA) 510(k) clearance in January of 2018. In 2010, AtriCure became the first company to receive clearance for a left atrial appendage management device.

AtriCure President and CEO Mike Carrel said the AtriClip FLEX•V enables easier deployment in open-chest surgeries, combining the lower-profile “V” Clip technology with a redesigned handle enabling a one-handed operation of the device.

The AtriClip FLEX•V has a rotatable and malleable shaft, allowing cardiac surgeons and hospital staff to adjust the AtriClip to adapt to specific patient anatomies. In addition, the new clip opening handle offers a reduced fatigue design to reposition the AtriClip multiple times before deployment to ensure the device is extended beyond the LAA and at the base.

For more information: www.atricure.com

 

Related Content

News | Cardiovascular Surgery

August 15, 2022 — Unnatural, direct connections between arteries and veins, like an access point for kidney dialysis and ...

Home August 15, 2022
Home
News | Cardiovascular Surgery

August 12, 2022 — Atrium Health Pineville has earned a distinguished three-star rating – the highest possible ...

Home August 12, 2022
Home
Feature | Cardiovascular Surgery

The global vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 ...

Home June 14, 2022
Home
News | Cardiovascular Surgery

June 14, 2022 — The Society for Vascular Surgery Vascular Quality Initiative (SVS VQI), a nonprofit organization ...

Home June 14, 2022
Home
News | Cardiovascular Surgery

April 29, 2022 – Paragonix Technologies, Inc., a leading organ preservation provider, announces today groundbreaking ...

Home April 29, 2022
Home
News | Cardiovascular Surgery
January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has ...
Home February 18, 2022
Home
News | Cardiovascular Surgery
February 15, 2022 – A multicenter, retrospective database analysis suggests improved open abdominal aortic aneurysm (AAA ...
Home February 15, 2022
Home
News | Cardiovascular Surgery

February 11, 2022 — Riverside Community Hospital has earned a distinguished three-star rating from The Society of ...

Home February 11, 2022
Home
News | Cardiovascular Surgery

November 23, 2021 — A novel device called venous external support (VEST) may lead to increased longevity and durability ...

Home November 23, 2021
Home
News | Cardiovascular Surgery

November 22, 2021 — The Minneapolis Heart Institute Foundation (MHIF) announced the publication of research showing ...

Home November 22, 2021
Home
Subscribe Now